提高免疫性血小板减少症患者脾切除术应答机会
本文为针对Mendoza等研究的评论。该研究对51例免疫性血小板减少症(ITP)患者行血小板闪烁显像,脾脏扣押者应答率87.5%,非脾脏破坏者45%;脾切除后血小板去唾液酸化在无应答者中更高,可能成为无应答的生物标志物,但需在脾切除前确认。
要点
- ITP血小板破坏主要因脾内自身抗体识别血小板,去唾液酸化可加速肝脏清除。
- 51例ITP患者血小板闪烁显像:脾脏扣押者应答87.5%,非脾脏破坏者45%。
- 脾切除后血小板去唾液酸化在无应答者中更高,可能为无应答生物标志物,需确认。
核心结论
- 脾脏扣押的ITP患者脾切除术应答率为87.5%,非脾脏破坏者为45%。
- 脾切除后血小板去唾液酸化在无应答者中更高,可能为无应答的潜在生物标志物,但需在脾切除前确认。
研究设计与样本
- 本文为针对Mendoza等研究的评论;该研究对51例ITP患者行血小板闪烁显像,并在脾切除后检测血小板去唾液酸化。
主要发现
- 51例ITP患者中,脾脏扣押者脾切除术应答率为87.5%,非脾脏破坏者为45%。
- 脾切除后血小板去唾液酸化在无应答患者中更高。
局限性
- 原文指出脾切除后血小板去唾液酸化结果需在脾切除前确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder characterized by isolated thrombocytopenia. Its pathogenesis is complex relying in large part on destruction of platelets recognized by autoantibodies within the spleen. However, other mechanisms, such as platelet desialylation, may play a role in platelet reduction by accelerating their clearance in the liver. In their study, Mendoza and colleagues reported on platelet scintigraphy performed in 51 ITP patients, showing a response in 87.5% when the sequestration occurred in the spleen versus 45% in case of non-splenic destruction. Platelet desialylation was also measured after splenectomy and found to be higher in non-responder patients. These latter results, while requiring confirmation prior to splenectomy, support platelet desialylation may also be a potential biomarker of non-response to splenectomy. Commentary on: Mendoza et al. Study of platelet kinetics in immune thrombocytopenia to predict splenectomy response. Br J Haematol 2024;204:315-323.
引用
- Audia S, Bussel J. Improving the chances of response to splenectomy in immune thrombocytopenia. Br J Haematol. 2023. PMID: 37939484. doi:10.1111/bjh.19174
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。